Verici DX Logo

Result of AGM and voting results

Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, announces that at the
Annual General Meeting (“AGM”) held earlier today, all resolutions were duly passed.
The voting results of the AGM were as follows:

  In Favour Against Withheld
Resolution Votes % Votes % Votes
1 62,212,695 100 0 0 0
2 62,212,118 100 577 0 0
3 62,212,545 100 0 0 150
4 52,879,826 85 9,332,869 15 0
5 51,490,878 83 10,720,067 17 1,750

 

Enquiries:

Sara Barrington, CEO
Julian Baines, Chairman

www.patientjourney.vericidx.com
Via Walbrook PR


N+1 Singer (Nominated Adviser & Broker)
Aubrey Powell / Kailey Aliyar / Tom Salvesen

Tel: 020 7496 3000


Walbrook PR Limited
Paul McManus / Sam Allen

Tel: 020 7933 8780 or [email protected]
Mob: 07980 541 893 / 07748 651 727

crossmenuchevron-down